Cargando…

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

Chronic kidney disease (CKD) is a major worldwide public health problem. The increase in the number of patients with CKD and end-stage kidney disease requesting renal dialysis or transplantation will progress to epidemic proportions in the next several decades. Although blocking the renin-angiotensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan-Ni, Liu, Hong-Jiao, Ren, Li-Li, Suo, Ping, Zou, Liang, Zhang, Ya-Mei, Yu, Xiao-Yong, Zhao, Ying-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432462/ https://www.ncbi.nlm.nih.gov/pubmed/36059935 http://dx.doi.org/10.3389/fphar.2022.964370

Ejemplares similares

Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
por: Luo, Liang-Pu, et al.
Publicado: (2021)

ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway
por: Wei, Hui-Ting, et al.
Publicado: (2022)

Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy
por: Wang, Wen-Wen, et al.
Publicado: (2021)

Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction
por: Zou, Junju, et al.
Publicado: (2022)

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
por: Li, Shan-Shan, et al.
Publicado: (2021)

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review
por: Alshahrani, Saeed
Publicado: (2023)

Targeting Renin–Angiotensin System Against Alzheimer’s Disease
por: Gebre, Abadi Kahsu, et al.
Publicado: (2018)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Potassium Intake Prevents the Induction of the Renin-Angiotensin System and Increases Medullary ACE2 and COX-2 in the Kidneys of Angiotensin II-Dependent Hypertensive Rats
por: Gonzalez, Alexis A., et al.
Publicado: (2019)

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
por: Xu, Ying, et al.
Publicado: (2021)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2021)

Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis
por: Xie, Feng, et al.
Publicado: (2023)

Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats
por: Chen, Rongchang, et al.
Publicado: (2022)

Stroke, High Blood Pressure and The Renin–Angiotensin–Aldosterone System – New Developments
por: Atkinson, Jeffrey
Publicado: (2011)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of Renin–Angiotensin–Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease
por: Yanai, Katsunori, et al.
Publicado: (2021)

Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway
por: Wang, Fujing, et al.
Publicado: (2022)

Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial
por: Mei, JuXiang, et al.
Publicado: (2021)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Effects of the Local Bone Renin-Angiotensin System on Titanium-Particle-Induced Periprosthetic Osteolysis
por: Zhao, Zhiping, et al.
Publicado: (2021)

Control of aging by the renin–angiotensin system: a review of C. elegans, Drosophila, and mammals
por: Egan, Brian M., et al.
Publicado: (2022)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling
por: Hu, Lichao, et al.
Publicado: (2022)

Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria
por: Fang, Hui, et al.
Publicado: (2023)

A Novel Modulator of the Renin–Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation
por: Zhang, Qi-Qiang, et al.
Publicado: (2022)

G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2015)

The Involvement of Renin-Angiotensin System in Lipopolysaccharide-Induced Behavioral Changes, Neuroinflammation, and Disturbed Insulin Signaling
por: Gong, Xiaoxue, et al.
Publicado: (2019)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
por: Ekholm, M., et al.
Publicado: (2021)

Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
por: Jo, Youngkwon, et al.
Publicado: (2022)

Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin–Angiotensin System Inhibitors: The Detection of Signals of Drug–Drug Interactions
por: Inaba, Ichiro, et al.
Publicado: (2019)

Effects of Shenkang Injection Combined with Jinshuibao on Early Diabetic Nephropathy and Effects on Coagulation Fibrinolysis System and Urinary Protein
por: Zhu, Jianhua, et al.
Publicado: (2022)

Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats
por: Li, Xiaoya, et al.
Publicado: (2020)

Pharmacokinetics and Metabolism Research of Shenkang Injection in Rats Based on UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS
por: Jiang, Xiaofang, et al.
Publicado: (2020)

Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis
por: Guo, Yuanyuan, et al.
Publicado: (2017)

Efficacy and safety of Shenkang injection as adjuvant therapy in patients with diabetic nephropathy: A protocol for systematic review and meta-analysis
por: Wang, Yanping, et al.
Publicado: (2020)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Avasimibe Alleviates Disruption of the Airway Epithelial Barrier by Suppressing the Wnt/β-Catenin Signaling Pathway
por: Zhou, Zicong, et al.
Publicado: (2022)

Roles of renin-angiotensin system and Wnt pathway in aging-related phenotypes
por: Kamo, Takehiro, et al.
Publicado: (2016)

Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury
por: Husková, Zuzana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8j34dnddngiia9v08h5ajgq0fi